SGX: Gain Exposure to Drivers of China’s New Economy with SGX FTSE China H50 Futures
SGX is excited to expand our China proposition with addition of the SGX FTSE China H50 Index Futures contract (“FCH”) to our pan-Asia shelf of equity derivatives products on 23 November 2020.
The FTSE China 50 Index is a hyper-liquid basket of stocks, tracking the top 50 biggest Chinese names listed in Hong Kong. FCH is closely correlated to other benchmark Hong Kong indices like HSCEI, but has a higher weightage in New Economy sectors like Tech, Consumer Services and Healthcare. With a high capping level of 9% for each individual constituent, traders can use FCH to gain quick access to tech and consumer giants like Tencent, Alibaba, Xiaomi and Meituan Dianping. In addition, FCH is well positioned for the “homecoming” of US-listed Chinese tech companies who seek secondary listings in Hong Kong. New mega-IPOs listed in Hong Kong will be eligible for Fast Entry into the FCH underlying index at close of business on the 5th day of trading.
China has bounced back from virus scares and the IMF projects China to be the world’s only economy with positive growth of 1.9% in 2020. In the longer-term, China’s growth is projected to accelerate to 8.2% in 2021. This provides a golden trading opportunity amidst a gloomy backdrop of expected 4.4% global contraction in 2020. With FCH, customers can ride on China’s fast recovery and express views on Mainland’s rapid expansion under China’s recently announced 5-year plan to drive domestic demand and power economic growth.
FCH is CFTC certified, quanto-USD denominated, and already well tracked by international institutional investors, with passive ETFs such as the iShares China Large Cap ETF (FXI) which alone has substantial AUM of more than US$3.4 billion. Given recent heightened market volatility due to ongoing US-China tensions and COVID-19, FCH is an excellent tool for risk management with SGX’s round-the-clock trading hours and overnight T+1 session until 5.15am Singapore time. Trading FCH on SGX is also highly cost-efficient with over 60% margin offsets against other liquid SGX equity derivatives products such as the SGX FTSE China A50, SGX SiMSCI, SGX Nikkei 225, SGX FTSE Taiwan and SGX Nifty index futures contracts.
*Projected GDP growth for China is from the IMF World Economic Outlook for October 2020
![Tables showing Key Index Features of FTSE China 50 Index and Top 10 Constituents](/sites/default/files/inline-images/SGX%20Chart%20for%20Nov%202020.jpg)
Disclaimers:
This document is not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) and/or its affiliates (collectively with SGX, the “SGX Group Companies”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document has been published for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Any forecast, prediction or projection in this document is not necessarily indicative of the future or likely performance of the product. Examples (if any) provided are for illustrative purposes only. While each of the SGX Group Companies have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties (if any). The SGX Group Companies may deal in investment products in the usual course of their business and may be on the opposite side of any trades. Each of SGX, Singapore Exchange Securities Trading Limited and Singapore Exchange Bond Trading Pte. Ltd. is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent. Please note that the general disclaimers and jurisdiction specific disclaimers found on SGX’s website at http://www.sgx.com/terms-use are also incorporated into and applicable to this document.
The SGX FTSE China H50 Index Futures (the “Product”) has been developed solely by Singapore Exchange Derivatives Trading Limited. The Index is calculated by FTSE International Limited (“FTSE”) or its agent. FTSE and its licensors are not connected to and do not sponsor, advise, recommend, endorse or promote the Product and do not accept any liability whatsoever to any person arising out of (a) the use of, reliance on or any error in the Index or (b) investment in or operation of the Product. FTSE makes no claim, prediction, warranty or representation either as to the results to be obtained from the Product or the suitability of the Index for the purpose to which it is being put by Singapore Exchange Derivatives Trading Limited.
“FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE under licence. All rights in the FTSE China 50 Index (the “Index”) vest in FTSE or its licensors. Neither FTSE nor Russell nor any of their affiliates or licensors: (a) assumes any liability, losses, damages, expenses or obligations in connection with any derivative product based on the Index; or (b) accepts any liability for any errors or omissions, fitness for a particular purpose or the results to be obtained from the use of the Index or related data. No party may rely on the Index or related data contained in this communication which Index and data is owned by FTSE or Russell or their affiliates. No use or distribution of the Index is permitted without FTSE’s or Russell’s express written consent. Neither FTSE nor Russell promotes, sponsors or endorses the content of this communication nor any financial or derivative product that it relates to.